Sort
78,016 grants matching “breast cancer”
Environmental Effect on the Mammary Gland across the Lifespan
$464,308Zena Werb · University Of California, San Francisco · U01 · FY2012 · ES
Mdm2 Alternative Splicing in DNA Damage and Cancer
$464,185Dawn S Chandler · Ohio State University · R01 · FY2025 · CA
A Wholly Protein-based Self-assembly Nanoplatform for TNBC-specific Combination Therapy
$464,182Rihe Liu · Univ Of North Carolina Chapel Hill · R01 · FY2024 · EB
Imaging Feedback to Guide Ultrasonic Tissue Fractionation for Cancer Therapy
$464,137Charles Alan Cain · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer
$464,117David Danforth · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA
TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression
$464,097Joan Massague · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
DHHC3 CONTRIBUTIONS TO BREAST CANCER
$464,058Dana-Farber Cancer Institute, Inc. · · FY2011 · Department of Defense
Active Delivery of Platinum Nanoimmunoconjugates to Improve Breast Cancer Therapy
$464,041Bogdan Olenyuk · Proteogenomics Research Instit/Sys/ Med · R01 · FY2020 · CA
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
$464,033Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Conserved Biology of Tumor and Microenvironment in Breast Cancer Progression
$464,025Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2011 · CA
Chemical disruption of Wnt-mediated signal transduction
$464,007James Kim · Ut Southwestern Medical Center · R01 · FY2017 · CA
Chemical disruption of Wnt-mediated signal transduction
$464,007Lawrence Lum · Ut Southwestern Medical Center · R01 · FY2015 · CA
Chemical disruption of Wnt-mediated signal transduction
$464,007Lawrence Lum · Ut Southwestern Medical Center · R01 · FY2016 · CA
High Resolution Peripheral Quantitative CT
$464,000Babette S Zemel · Children'S Hosp Of Philadelphia · S10 · FY2013 · OD
In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria
$463,994Linnie Golightly · Weill Medical Coll Of Cornell Univ · R33 · FY2025 · HL
Comprehensive minimal residual disease tracking in cancer
$463,940G. Mike Makrigiorgos · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Immunometabolic pathways enabled by PARP inhibition in breast cancer
$463,884Jennifer L. Guerriero · Brigham And Women'S Hospital · R37 · FY2023 · CA
HAWAII MINORITY-BASED CCOP
$463,871University Of Hawaii At Manoa · U10 · FY2000 · CA
Nanotechnology enabled targeting of p53 deficiency in human cancer
$463,867Xiaoming He · Univ Of Maryland, College Park · R01 · FY2020 · CA
Deciphering the Code for Senescence Escape During Cancer Progression in Humans
$463,817Utz Herbig · Rbhs-New Jersey Medical School · R01 · FY2019 · CA
Systems Biology of Antigen and T-Cell Transport in Cancer Immunotherapy
$463,816Timothy P Padera · Massachusetts General Hospital · R01 · FY2024 · CA
Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy
$463,813Anand T.n. Kumar · Massachusetts General Hospital · R01 · FY2021 · CA
An integrated community-clinic model of optimized implementation strategies to increase early detection of breast and cervical cancers in Kenya
$463,808Sujha Subramanian · Implenomics Llcs · R01 · FY2023 · CA
Measuring and Modulating DNA Damage Surveillance Pathways
$463,803Eric T. Kool · Stanford University · R01 · FY2024 · CA
NYU COOPERATIVE PROSTATE CANCER TISSUE RESOURCE
$463,767New York University School Of Medicine · U01 · FY2002 · CA